Parties’ Reservation of Rights Defeats Attempt to Enforce Settlement in Principle
The author writes "A recent federal case in New York presents an instructive look at a court’s evaluation of whether an email ...
The National Law Review2d
New York Federal Court Ruling Highlights a Potential Pitfall in Settlement Agreement Enforcement
On January 8, 2025, the U.S. District Court for the Eastern District of New York held that an employee’s refusal to sign a ...
Yahoo Finance4d
Axsome Therapeutics Announces Settlement Agreement Resolving AUVELITY® (dextromethorphan HBr – bupropion HCl) Patent Litigation
The settlement agreement resolves all outstanding patent litigation relating to AUVELITY. “Axsome is proud of its commitment to innovating treatments aimed at improving the lives of the millions ...
Nasdaq5d
Axsome Therapeutics Reaches Settlement With Teva On AUVELITY Patent Litigation
(RTTNews) - Biopharmaceutical company Axsome Therapeutics, Inc. (AXSM) announced that it has entered into a settlement agreement with Teva Pharmaceuticals, Inc. resolving all patent litigation ...
Disqualification Row Emerges in $2.8B Blue Cross Settlement as Opt-Out Deadline Approaches
March 4 is the deadline for health care providers to decide whether or not they want to stay in a proposed settlement with ...
Business Insider5d
Axsome announces settlement agreement resolving AUVELITY patent litigation
Axsome Therapeutics (AXSM) announced that it has entered into a settlement agreement with Teva Pharmaceuticals (TEVA) resolving all patent litigation related to Axsome’s AUVELITY product.
manilatimes6d
Axsome Therapeutics Announces Settlement Agreement Resolving AUVELITY® (dextromethorphan HBr - bupropion HCl) Patent Litigation
In accordance with the agreement, the parties will terminate all ongoing litigation between Axsome and Teva regarding AUVELITY patents pending in the U.S. District Court for the District of New Jersey ...